NCT04542434View on ClinicalTrials.gov

Niclosamide in COVID-19

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 20, 2022

Primary Completion Date

January 20, 2022

Study Completion Date

January 20, 2022

Conditions
Covid19
Interventions
DRUG

Niclosamide Oral Tablet

Niclosamide tablets 400 mg 3 times daily for 14 days

DRUG

Placebo

Matching placebo tablets 3 times daily for 14 days

Sponsors
All Listed Sponsors
lead

Entero Therapeutics

INDUSTRY